Clinical Trials Logo

Allergy clinical trials

View clinical trials related to Allergy.

Filter by:

NCT ID: NCT00836368 Completed - Asthma Clinical Trials

In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics

Gammaphil
Start date: December 2008
Phase: Phase 1
Study type: Interventional

Purpose: This is a non-masked study with a primary endpoint of in vitro basophil activation by the allergen D. farinae, comparing basophil activation before and after seven days of supplementation. Secondary endpoints will include circulating antioxidant levels (tocopherols and metabolites), in vitro basophil activation to IgG anti-IgE and to N-formyl-methionyl-leucyl-phenylalanine (f-met-leu-phe), and monocyte and basophil responsiveness to in vitro endotoxin challenge. Participants: Twenty allergic asthmatic volunteers Procedures (methods): Volunteers will be given 1200 mg of a gamma tocopherol enriched supplement, a commercially available supplement form of vitamin E. Study participants will undergo assessment of general health, lung function assessment, symptom scoring, and epicutaneous skin test to allergens at baseline and after supplementation. Blood samples will be collected at baseline and after 7 days of gamma-T treatment.

NCT ID: NCT00807547 Completed - Allergy Clinical Trials

Intraseasonal Short-time Up-dosing With Alutard SQ Grasses

Start date: April 2008
Phase: Phase 3
Study type: Interventional

Test of pharmacodynamic efficacy and tolerability of a short-time intra-seasonal updosing

NCT ID: NCT00806364 Completed - Healthy Clinical Trials

Normal Blood, Bone Marrow and Buccal Mucosa Protocol

Start date: March 26, 2009
Phase:
Study type: Observational

This protocol is designed to provide blood, buccal mucosa and bone marrow aspirate samples from approximately 250, healthy volunteer donors for use in in vitro studies of mast cells, mastocytosis, and allergic diseases. Non-atopic donors will be recruited to donate blood, bone marrow, and/or buccal mucosa samples using conventional techniques. The investigational nature of the studies in which their blood, bone marrow and buccal mucosa samples will be used, as well as the risks and benefits of the donation process will be explained to all donors, and a signed informed consent document will be obtained. Donors will be compensated according to an established schedule based on the duration and discomfort of the donations. Samples provided through this protocol will be used solely for in vitro research. Blood, bone marrow, and buccal mucosa samples will be assigned a unique product number and the study investigators listed on this protocol will serve as the custodians of the code that links the product with a donor s identity. The nature of the in vitro studies in which the blood collected in this study will be used is not the subject of this protocol and will be described in general terms only. The samples will be used in several Institutional Review Board (IRB)-approved Laboratory of Allergic Diseases (LAD) protocols. This protocol is designed to assure adequate and complete informed consent, counseling, and protection of the study subjects according to IRB, Office of Human Subjects Research (OHSR), Office for Human Research Protections (OHRP) and other applicable Federal regulatory standards.

NCT ID: NCT00805402 Completed - Allergy Clinical Trials

Interest of Flow Cytometry for the Diagnosis, the Follow up and Specific Immunotherapy (SIT) Arrest of Hymenoptera Venom Allergy

Cytoven
Start date: July 2008
Phase: N/A
Study type: Interventional

The aim of this study is to show that flow cytometry can be an accurate tool to help physicians regarding the diagnosis, the SIT decision and the SIT arrest of hymenoptera venom allergy. 75 patients having a story of reaction to hymenoptera venom will be selected for this trial. Blood samples will be analyzed at: inclusion visit, Week 1 visit, Week 3 visit, Week 10 and Week 21 visit.

NCT ID: NCT00798226 Active, not recruiting - Asthma Clinical Trials

Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood

Start date: November 26, 2008
Phase: Phase 1
Study type: Interventional

The aim of this study is to prevent asthma and allergies in childhood by supplementation with fish oil (n-3 fatty acids) to the mother during pregnancy. Paticipants are mother and children participating in the ABC-(Asthma Begins in Childhood)cohort. Mothers are recruited during pregnancy and receive supplement with n-3 fatty acids or olive oil (placebo) from week 24 of gestation to 1 week after delivery. The child is followed with acute and planned visit at the research unit and diagnosis of disease is done in the research unit according to predefined algorithms.

NCT ID: NCT00740974 Completed - Asthma Clinical Trials

Allergy and Asthma Following Children Who Were Fed Supplemented Infant Formula

Start date: n/a
Phase: N/A
Study type: Observational

Long-term cognitive outcome study of children who participated in randomized trials of LCP-supplemented formula during infancy.

NCT ID: NCT00718133 Completed - Allergy Clinical Trials

The Effect of Air Pollution on Lung Health Among Children Living in Haifa Bay Region, Israel

Start date: December 2008
Phase: N/A
Study type: Interventional

Haifa bay region is located close to a major industrial zone. The aim of the study is to evaluate the health status of children living in Haifa bay region. The health status will be evaluated using health questionnaires and spirometry.

NCT ID: NCT00717899 Completed - Allergy Clinical Trials

The Effect of Air Pollution on Lung Health Among School Children Living in Haifa Bay Region

Start date: December 2008
Phase: N/A
Study type: Interventional

Haifa bay region is located close to a major industrial zone. The aim of the study is to evaluate the health status of school children living in Haifa bay region.The health status will be evaluated using health questionnaires and spirometry.

NCT ID: NCT00689299 Completed - Allergy Clinical Trials

Phase 2 Study in Adults Sensitized to Cat

Start date: October 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to identify an effective dose of allergen-specific immunotherapy for cat hair (Felis domesticus) administered by the oral/sublingual route.

NCT ID: NCT00673218 Active, not recruiting - Allergy Clinical Trials

The Effect of Xolair on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils

Start date: June 2007
Phase: Phase 4
Study type: Interventional

If you are allergic to ragweed, and not taking certain medications, you will be asked to have blood drawn. We will perform experiments on your blood cells.